ea0083to3 | Thyroid | EYES2022
R. Corleto
, G. Boselli
, G. Margiotta
, M. L. Monzani
, A. Craparo
, M. Locaso
, S. Sperduti
, N Roy
, M. Simoni
, V. Rochira
, D. Santi
, G. Brigante
Introduction: Despite normal thyroid stimulating hormone (TSH) serum levels, 10% of hypothyroid patients treated with LT4 complain of hypothyroidism symptoms, likely linked to decreased availability of free triiodothyronine (fT3). Thus, combined levothyroxine/liothyronine (LT4/lT3) therapy was suggested to ensure a more physiological balance in peripheral tissues.Aim: To evaluate the effectiveness of combined LT4/lT3 therapy in thyroidectomized subjects,...